Nan Fung Group Holdings Ltd
Filing Date
Global Rank
#4,939
/ 8,232
▲ 480
Top Industry
Biotechnology
97.5%
3Y Alpha vs SPY
-22.6%
Period ended 2 months ago
Filed May 14, 2026 · 31d
20 quarters · since Jun 2021
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
-5.3%
SPY
+76.3%
Annualised alpha
-22.6%
Max drawdown
−38.8%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
23 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
27.3%
+5.2 pts
Top 5
68.4%
+9.5 pts
Top 10
83.5%
+3.5 pts
HHI
1,329
Diversified+317
Portfolio Trend
20 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 96.3% | $116,694,731 |
| Technology | 2.5% | $3,038,043 |
| Unclassified | 1.2% | $1,413,680 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| LBRX | Lb Pharmaceuticals Inc | +330,657 | 630,657 | $15,552,001 | |
| No positions match the current search. | |||||
Sold Out
Positions the filer fully exited
5 positions
1 positions ·
$3,038,043 total
· Technology only
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| PCOR |
Procore Technologies, Inc.
Technology
|
Held | 53,299 | $3,038,043 | 100.00% |